Celltrion, Foreign Investors Net Buy 84,538 Shares... Stock Price Up 2.6%

As of 2:32 PM on the 25th, Celltrion is trading at 256,500 KRW, up 2.6% from the previous day. This is a 19.34% decrease compared to September 8. Celltrion is known as a protein and biopharmaceutical manufacturing company.

Today, foreigners have a tentative net purchase of 84,538 shares of Celltrion, and institutions have a net purchase of 14,000 shares. Over the past five days, individual investors have net purchased 1,597 shares, while foreigners and institutions have net purchased 232,099 shares and net sold 234,412 shares, respectively.

On September 18, Celltrion was a market issue due to the "approval news of Phase 2 and 3 clinical trials for the COVID-19 treatment," which caused its stock price to rise.

[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.